Suggestion of Tunisia's medical oncologist in the management of breast cancer during COVID-19 pandemic.
Yosra YahyaouiZahra GhodhbaniAdel HamdiFeryel LetaiefYosr ZenzriAzza Ben SaidImen BlouzaAmel MezliniPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)
Cancer patients are at higher risk to be infected with COVID-19 and to develop a more severe form. Breast cancer (BC) treatments, including chemotherapy (CT), targeted therapy and immunotherapy can weaken the immune system and possibly cause lung problems. For all these reasons Salah Azaiez Institute's department of Medical Oncology took drastic actions to protect patients. In this article we will discuss protocol adjustments taken during the COVID-19 pandemic for breast cancer patients.
Keyphrases
- end stage renal disease
- healthcare
- newly diagnosed
- coronavirus disease
- sars cov
- ejection fraction
- chronic kidney disease
- mental health
- palliative care
- computed tomography
- randomized controlled trial
- prognostic factors
- early onset
- squamous cell carcinoma
- magnetic resonance imaging
- radiation therapy
- patient reported outcomes
- contrast enhanced
- breast cancer risk
- tertiary care
- rectal cancer
- respiratory syndrome coronavirus
- drug induced
- childhood cancer